Skip to content

Prognostic Value of PLR On Cardiovascular Complications in Chronic Hemodialysis Patients

Prognostic Value of the Platelet to Lymphocyte Ratio on Cardiovascular Complications in Chronic Hemodialysis Patients

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07519785
Enrollment
80
Registered
2026-04-09
Start date
2024-01-04
Completion date
2024-08-04
Last updated
2026-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Complications in Hemodialysis

Keywords

platelet to lymphocyte ratio

Brief summary

Prognostic value of platelet to lymphocyte ratio on cardiovascular complications in chronic hemodialysis patients this study was done to determine the prognostic value of PLR on cardiovascular complications like vascular calcifications and atherosclerosis in carotid and coronary arteries in chronic hemodialysis patients

Detailed description

Prognostic value of platelet to lymphocyte ratio on cardiovascular complications in chronic hemodialysis patients this study was done to determine the prognostic value of PLR on cardiovascular complications like vascular calcifications and atherosclerosis in carotid and coronary arteries as these complications are common and well-known causes of morbidity and mortality in chronic hemodialysis patients

Interventions

None listed

Sponsors

Minia University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* patients undergoing hemodialysis for more than 3 months who agreed to be included in the study

Exclusion criteria

* We are going to exclude patients who have: * Younger than 18 year- old or Older than 75 year-old, * Patients with positive serum marker of anti-hepatitis C virus (anti-HCV), hepatitis B surface antigen (HBsAg) and human immunodeficiency virus (HIV). * Alcohol or illicit drug abusers. * Inflammatory state due to infection,

Design outcomes

Primary

MeasureTime frameDescription
To evaluate the association between platelet-to-lymphocyte ratio and cardiovascular complications in patients on chronic maintenance hemodialysis.6 monthsPrimary Outcome Association between PLR and cardiovascular complications in chronic hemodialysis patients. Secondary Outcomes optimal PLR cutoff for cardiovascular complication prediction relation of PLR to individual cardiovascular diagnoses relation of PLR to cardiovascular hospitalization relation of PLR to cardiovascular mortality

Countries

Egypt

Contacts

STUDY_CHAIRHassan Mohammad Mohyedin, Professor of internal medicine

faculty of medicine elminya university

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 14, 2026